Skip to main content

Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria

Abstract

Purpose

To define the percentage of small (≤2 cm) hepatocellular carcinoma (HCC) nodules showing the diagnostic enhancement pattern at CEUS, computed tomography (CT), and gadobenate dimeglumine (Gd-BOPTA)—enhanced magnetic resonance (MR) imaging.

Methods

42 cirrhotic patients (26 male, 16 female; 67 ± 12 years) with 46 biopsy-proven HCCs ≤2 cm were included. Each HCC was scanned by CEUS, contrast-enhanced CT, and Gd-BOPTA-enhanced MR imaging. Nodule enhancement was evaluated by two readers. Independent analysis was followed by consensual analysis and the proportion of HCCs with the diagnostic enhancement pattern (nodule hyperenhancing on hepatic arterial phase and hypoenhancing on portal venous—late phase) on CEUS, CT, and MR imaging was compared by chi-square test.

Results

Very good inter-reader agreement was observed on hepatic arterial phase and portal venous—late phase: CEUS, k = 0.89 and 0.85; CT, k = 0.91 and 0.88; MR imaging, k = 0.96 and 0.94. CEUS and CT did not differ in the percentage of HCC nodules with a diagnostic enhancement pattern (18/46 and 16/46; P = 0.66), while MR imaging revealed the diagnostic pattern in higher percentage of nodules (29/46; P = 0.012) in comparison to CEUS and CT.

Conclusions

CEUS and contrast-enhanced CT did not differ in the percentage of small HCC nodules with diagnostic enhancement pattern, while Gd-BOPTA-enhanced MR imaging revealed the diagnostic pattern in a higher nodule number in comparison to CEUS and CT.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3

References

  1. Hayashi M, Matsui O, Ueda K, et al. (2002) Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material. Radiology 225:143–149

    PubMed  Article  Google Scholar 

  2. Asayama Y, Yoshimitsu K, Nishihara Y, et al. (2008) Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic–pathologic correlation. AJR Am J Roentgenol 190:W28–W34

    PubMed  Article  Google Scholar 

  3. Luca A, Caruso S, Milazzo M, et al. (2010) Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants. Eur Radiol 20:898–907

    PubMed  Article  Google Scholar 

  4. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

    PubMed  Article  Google Scholar 

  5. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL–EORTC Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943

    Google Scholar 

  6. Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51:2020–2029

    PubMed  Article  Google Scholar 

  7. Quaia E, D’Onofrio M, Cabassa P, et al. (2007) The diagnostic value of hepatocellular nodule vascularity after sulfur hexafluoride-filled microbubble injection in patients with liver cirrhosis: analysis of diagnostic performance and confidence in malignancy characterization. AJR Am J Roentgenol 189:1474–1483

    PubMed  Article  Google Scholar 

  8. Quaia E, Alaimo V, Baratella E, et al. (2009) The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis. Eur Radiol 19:651–663

    PubMed  Article  Google Scholar 

  9. Sangiovanni A, Manini MA, Iavarone M, et al. (2010) The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis. Gut 59:638–644

    PubMed  Article  Google Scholar 

  10. WORLD Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects, 2008. http://www.wma.net/en/30publications/10policies/b3/index.html. Accessed 2 Feb 2013

  11. The International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658–664

    Article  Google Scholar 

  12. Sultana S, Awai K, Nakayama Y, et al. (2007) Hypervascular hepatocellular carcinomas: bolus tracking with a 40-detector CT scanner to time arterial phase imaging. Radiology 243:140–147

    PubMed  Article  Google Scholar 

  13. Bismuth H (1982) Surgical anatomy and anatomical surgery of the liver. World J Surg 6:3–8

    PubMed  Article  CAS  Google Scholar 

  14. Coinaud C (1957) Le foie: études anatomiques et chirurgicales. Paris: Masson, pp 9–12

    Google Scholar 

  15. Kundel HL, Polansky M (2003) Measurement of observer agreement. Radiology 228:303–308

    PubMed  Article  Google Scholar 

  16. Forner A, Vilana R, Ayuso C, et al. (2008) Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 47:97–104

    PubMed  Article  Google Scholar 

  17. Furlan A, Marin D, Cabassa P, et al. (2012) Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines. Eur J Radiol 81:2099–2105

    PubMed  Article  Google Scholar 

  18. Rimola J, Forner A, Tremosini S, et al. (2012) Noninvasive diagnosis of hepatocellular carcinoma 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI. J Hepatol 56:1317–1323

    PubMed  Article  Google Scholar 

  19. Serste T, Barrau V, Ozenne V, et al. (2012) Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology 55:800–806

    PubMed  Article  Google Scholar 

  20. Shaib YH, El Serag HB, Nooka AK, et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital based case–control study. Am J Gastroenterol 102:1016–1021

    PubMed  Article  Google Scholar 

  21. Murakami T, Nakamura H, Tsuda K, et al. (1995) Contrast-enhanced MR imaging of intrahepatic cholangiocarcinoma: pathologic correlation study. J Magn Reson Imaging 5:165–170

    PubMed  Article  CAS  Google Scholar 

  22. Chen LD, Xu HX, Xie XY, et al. (2010) Intrahepatic cholangiocarcinoma and hepatocellular carcinoma: differential diagnosis with contrast-enhanced ultrasound. Eur Radiol 20:743–753

    PubMed  Article  CAS  Google Scholar 

  23. Foschi FG, Dall’aglio AC, Marano G, et al. (2010) Role of contrast-enhanced ultrasonography in primary hepatic lymphoma. J Ultrasound Med 29:1353–1356

    PubMed  Google Scholar 

  24. Caturelli E, Bartolucci F, Biasini E, et al. (2002) Diagnosis of liver nodules observed in chronic liver disease patients during ultrasound screening for early detection of hepatocellular carcinoma. Am J Gastroenterol 97:397–405

    PubMed  Article  Google Scholar 

  25. Claudon M, Cosgrove D, Albrecht T, et al. (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS): update 2008. Ultraschall Med 29:28–44

    PubMed  Article  CAS  Google Scholar 

  26. Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendatios for contrast-enhanced ultrasound (CEUS) in the liver: update 2012. A WFUMB—EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS, and ICUS. Ultrasound Med Biol 39:187–210

    PubMed  Article  Google Scholar 

  27. Clinical Practice Guidelines for Hepatocellular Carcinoma—The Japan Society of Hepatology 2009 update (2010) Diagnosis and surveillance. Hepatol Res 40: 16–47

    Google Scholar 

  28. Kudo M, Izumi N, Kokudo N, et al. (2011) Management of hepatocellular carcinoma in Japan: consensus-based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29:339–364

    PubMed  Article  Google Scholar 

  29. Omata M, Lesmana LA, Tateishi R, et al. (2010) Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatol Int 4:439–474

    PubMed  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emilio Quaia.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Quaia, E., De Paoli, L., Angileri, R. et al. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. Abdom Imaging 38, 1245–1253 (2013). https://doi.org/10.1007/s00261-013-0031-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-013-0031-7

Keywords

  • Hepatocellular carcinoma
  • Microbubbles
  • Ultrasound
  • Contrast-enhanced ultrasound
  • Computed tomography
  • Magnetic resonance imaging